Imaging autoimmune diabetes

January 29, 2014

Researchers at Lund University have managed to develop a technique whereby they can study the inflammatory process that takes place in the pancreas during the natural development of type 1 diabetes, allowing for real time and repeated non-invasive imaging of individual islets of Langerhans. The technique enables the visualisation of a human autoimmune disease in animal models that gives us a way to watch the body´s response to new therapeutic strategies that attempt to save islets from this deadly immune system attack.

Anja Schmidt-Christensen and Dan Holmberg are two of the researchers behind the study.

"The main breakthrough with this technique we have developed is that inflammatory processes from now on can be studied in the actual autoimmune disease situation that takes place in the pancreas during the natural development of type 1 diabetes," said Dan Holmberg, Professor of Immunology.

By transplanting individual of Langerhans, to the anterior chamber of the eye in the mouse model for type 1 diabetes, the researchers have been able to follow the inflammatory process in through a sophisticated microscope in a way that was not previously possible.

In type 1 diabetes, the Islets of Langerhans in the pancreas are partly made up of insulin-producing beta cells, and do not produce sufficient quantities of the hormone insulin mainly due to the autoimmune destruction and killing of beta-cells by the body's own immune system.

Initially, the researchers had certain misgivings about the model, because immune defense mechanisms are believed to be suppressed in the eye to protect vision, the so called immune privileged status of the eye. However, in the light of all previous knowledge of the in the pancreas in , the researchers have been able to demonstrate that the process in the transplanted islets in the eye recapitulates the autoimmune insulitis in the pancreas. This is fundamental to the model and research findings that have now been presented.

"It is also clear that the images we produce are high quality. The major advantage of this technique is unlike with any other existing non-invasive techniques like MRI and PET – the high cellular resolution making it possible to see individual cells and monitor how they move and interact with each other.

"But the uniqueness of this model is that the imaging can be performed on the very same islet(s) of individual animals multiple times during a follow-up period, whereas other techniques with similar resolution require invasive surgery and only allow single snapshot images," said Anja Schmidt-Christensen, who is joint first author of the study with Lisbeth Hansen.

Researchers can now study how the process progresses from day to day and over the course of months, how the invading inflammatory cells enter the Islets of Langerhans, how they move and interact, multiply and finally destroy the insulin-producing beta cells.

"This gives us new opportunities to see the body's reaction to different treatment strategies to save the islets from the immune system's deadly attacks. It opens up the way to many new areas. One thing we really want to do, and have the technology to do in the future, is to create a model of the human immune system and transplant cell islets from humans," said Dan Holmberg.

Explore further: Reading the pancreas through the eye: Researchers describe innovative way to study body glucose regulation

More information: "Imaging dynamics of CD11c+ cells and Foxp3+ cells in progressive autoimmune insulitis in the NOD mouse model of type 1 diabetes." A. Schmidt-Christensen, L. Hansen, E. Ilegems, N. Fransén-Pettersson, U. Dahl, S. Gupta, Å. Larefalk, T. Dahlbaek Hannibal, A. Schulz, P.-O. Berggren, D. Holmberg. Diabetologia. link.springer.com/article/10.1 … 07/s00125-013-3024-8

Related Stories

Reading the pancreas through the eye: Researchers describe innovative way to study body glucose regulation

November 18, 2013
Researchers at Karolinska Institutet in Sweden have found an innovative way to study glucose regulation in the body: by transferring the vital insulin-producing cells from the pancreas to the eye, the latter can serve as ...

New research redraws pancreas anatomy

July 6, 2011
(Medical Xpress) -- Research from Karolinska Institutet shows that insulin secretion in the pancreas is not under direct neural control, as has previously been thought. The few nerves that are present are connected to blood ...

Study identifies immune cells that promote growth of beta cells in type 1 diabetes

September 27, 2013
Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears ...

Adult stem cells could hold key to curing Type 1 diabetes

May 29, 2013
Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, ...

The role of the innate immune cells in the development of type 1 diabetes

December 19, 2012
Julien Diana and Yannick Simoni of the "Immune Mechanisms in Type 1 Diabetes," Inserm/Université Paris Descartes, directed by Agnès Lehuen, have just published the results of their work on type 1 diabetes in the Nature ...

New mouse model confirms how type 2 diabetes develops

May 3, 2013
Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment. Long-term ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.